RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/8827523http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/8827523http://www.w3.org/2000/01/rdf-schema#comment"The human apolipoprotein (apo) C-IV gene has been recently identified: it is closely linked to the promoter region of the apoC-II gene (Allan, C.M., D. Walker, J. Segrest, and J. M. Taylor. 1995. Genomics. 28: 291-300). To determine the effect of apoC-IV gene expression on lipoprotein metabolism, transgenic mice were generated using a human apoC-IV cDNA construct. Human apoC-IV was found associated with plasma lipoproteins (d < 1.21 g/ml), mainly in very low density lipoproteins (VLDL), and higher molecular mass isoforms were present, due to N-linked glycosylation and variable sialylation of apoC-IV. Human apoC-IV transgenic mice were hypertriglyceridemic compared to nontransgenic controls; the accumulated plasma triglycerides were present mainly in VLDL. There was little change in plasma cholesterol levels, although apoC-IV expression redistributed cholesterol to VLDL and larger particles in low density lipoprotein/large high density lipoprotein fractions. By immunoblot analysis, apoC-IV was not detected in normal adult human plasma or isolated plasma lipoproteins, a finding consistent with our previous observation of very low levels of human apoC-IV mRNA in human liver. However, our analysis of transgenic mice provides unequivocal evidence that human apoC-IV is a lipid-binding protein belonging to the apolipoprotein family and that it has the potential to alter lipoprotein metabolism."xsd:string
http://purl.uniprot.org/citations/8827523http://purl.uniprot.org/core/author"Taylor J.M."xsd:string
http://purl.uniprot.org/citations/8827523http://purl.uniprot.org/core/author"Allan C.M."xsd:string
http://purl.uniprot.org/citations/8827523http://purl.uniprot.org/core/date"1996"xsd:gYear
http://purl.uniprot.org/citations/8827523http://purl.uniprot.org/core/name"J Lipid Res"xsd:string
http://purl.uniprot.org/citations/8827523http://purl.uniprot.org/core/pages"1510-1518"xsd:string
http://purl.uniprot.org/citations/8827523http://purl.uniprot.org/core/title"Expression of a novel human apolipoprotein (apoC-IV) causes hypertriglyceridemia in transgenic mice."xsd:string
http://purl.uniprot.org/citations/8827523http://purl.uniprot.org/core/volume"37"xsd:string
http://purl.uniprot.org/citations/8827523http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/8827523
http://purl.uniprot.org/citations/8827523http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/8827523
http://purl.uniprot.org/uniprot/P55056#attribution-24757F900CB9844E9C5D0351F0FE35EAhttp://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/8827523